US Stock Movement | Zai Lab (ZLAB.US) rises over 2% with positive Phase Ib data for investigational ADC Zoci
智通财经2026/10/23 15:50Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Zhihu Finance APP reports that on Friday, Zai Lab (ZLAB.US) shares surged nearly 10% in early trading and, as of press time, were up more than 2% at $22.62. According to reports, on October 23, Zai Lab announced the global Phase Ib clinical study data of its investigational antibody-drug conjugate (ADC) Zocilurtatug Pelitecan (short name “Zoci”, previously codenamed ZL-1310) for first-line extensive-stage small cell lung cancer. The related results will be presented on October 26 at the 2026 European Society for Medical Oncology (ESMO) Congress.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Libya Hamada and Al-Taharah oil fields resume production
智通财经•2026/10/24 12:41
No rate hike in October, another move in December? Fed's "slow rate hike" path against inflation emerges, all eyes on Waller's speech next week
The Federal Reserve is set to announce its latest interest rate decision next Wednesday. The market generally expects the central bank to keep the federal funds rate unchanged, which would signal its patience in combating inflation.
智通财经•2026/10/24 06:56
